A common problem encountered in enantioselective organocatalysis is the aggregation of the catalyst, which can result in a relevant decrease of the efficiency and selectivity of the process. In the asymmetric synthesis of chiral benzofuranones, recently reported by us, we noted a remarkable increase of the reaction yield upon the addition of one of the reagents in a portionwise manner rather than in a single addition. We investigated this phenomenon by several experimental techniques such as 1D and 2D NMR experiments, UV-Vis spectroscopy, circular dichroism and dynamic light scattering. In addition, we studied the kinetic profile of this reaction using a simple numerical model and carried out in silico investigations. All these different approaches point to the conclusion that in the reaction medium a supramolecular polymerization/aggregation phenomenon, based on weak interactions, occurs and such a process is promoted by a quinone, which is one of the reagents of the benzofuranone synthesis. The portionwise mode of addition is a known strategy which can improve the performance of many synthetic procedures and this strategy is commonly adopted on account of empirical experience. However, our results provide an explanation, based on a chemical kinetic model, of the reason why the portionwise addition affects in such a dramatic way the yield of the benzofuranone synthesis catalyzed by Cinchona alkaloids.
Benzazetidines are a class of N‐heterocycles potentially very interesting for a variety of purposes, including biological applications and drug design. In the past, their high ring strain has hampered the development of trustable, general, and efficient synthetic methodologies for their preparation. In this review article, the aim is to disclose all the literature contributions about the synthesis of these compounds and the study of their reactivity, from the early examples to the most recent synthetic approaches. Recently, there has been a growth of interest for this heterocycle, driven by the publication of novel synthetic methodologies based on palladium‐catalyzed intramolecular C−H amination and organocatalyzed ring‐closure of 2‐(N‐Boc‐anilino)‐α‐ketoesters/amides.
The global demand for medical radionuclides is rapidly increasing, driven by the expansion of diagnostic and therapeutic radiopharmaceuticals, and by recurrent vulnerabilities in international supply chains. While high-flux reactors remain the backbone of large-scale isotope production, low- and medium-power research reactors—such as TRIGA facilities—offer valuable opportunities for decentralised, flexible, and alternative radionuclide generation. Several studies have demonstrated their capability to produce emerging therapeutic or diagnostic isotopes, including 111Ag, 99Mo/99mTc, 64Cu, 177Lu, and 161Tb, although with yield limitations inherent to moderate neutron flux levels. In Europe, recent initiatives such as PRISMAP, SIMPLERAD, and SECURE aim to strengthen production capacity and diversify radionuclide availability. Within this framework, Italy—lacking operational power reactors—seeks alternative routes to ensure a resilient national supply. This work presents the investigation carried out within the SECURE project to assess the feasibility of an Italian production cycle for medical-grade 161Tb at the ENEA TRIGA RC-1 Research Reactor (Rome). The study integrates reactor-specific irradiation analyses, the development of chemical separation and target recovery processes, and a comprehensive economic evaluation within a full lifecycle perspective. The results highlight the potential and constraints of a TRIGA-based production for supporting future Italian theranostic needs.